MBX
NASDAQStockMBX Biosciences, Inc. Common Stock
$27.45-0.50 (-1.79%)
52-Week Range
$5.79
$43.14
Key Stats
Market Cap
922.1M
P/E Ratio
3.57
Dividend Yield
—
Beta
1.07
Volume
482.2K
Avg Volume
591.4K
Performance
1M
-26.45%
3M
-1.52%
6M
+157.13%
YTD
-8.51%
1Y
+221.26%
3Y
+18.18%
5Y
+18.18%
Price Chart
ETF Exposure
MBX is held by 63 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| IWV | iShares Russell 3000 ETF | 0.00% |
| SCHB | Schwab U.S. Broad Market ETF | 0.00% |
| VEQT.TO | Vanguard All-Equity ETF Portfolio | 0.00% |
| XEQT.TO | iShares Core Equity ETF Portfolio | 0.00% |
| XUU.TO | iShares Core S&P U.S. Total Market Index ETF | 0.00% |
| DFUS | Dimensional - US Equity Market ETF | 0.00% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.00% |
| VCNS.TO | Vanguard Conservative ETF Portfolio | 0.00% |
| VRIF.TO | Vanguard Retirement Income ETF Portfolio | 0.00% |
PreviousPage 2 of 2
About MBX ETF Exposure
MBX Biosciences, Inc. Common Stock (MBX) is held by 63 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 922.1M, MBX is a widely held institutional stock. The stock currently trades at $27.45. Investors can gain exposure to MBX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold MBX, sorted by portfolio weight.